ASST Asset Entities Inc

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 20, 2025

 

ASSET ENTITIES INC.

(Exact name of Company as specified in its charter)

 

Nevada		001-41612		88-1293236
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

100 Crescent Ct, 7th Floor, Dallas, TX		75201
(Address of principal executive offices)		(Zip Code)

 

	(214) 459-3117
	(Company’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class B Common Stock, $0.0001 par value per share		ASST		The Nasdaq Stock Market LLC

 

Indicate by check mark whether the Company is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging Growth Company ☒

 

If an emerging growth company, indicate by check mark if the Company has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On March 20, 2025, Asset Entities Inc., a Nevada corporation (the “Company”), entered into an Amended and Restated Waiver and Consent, dated as of March 20, 2025 (the “A&R Ionic ATM Waiver”), between the Company and Ionic Ventures, LLC, a California limited liability company (“Ionic”), the sole holder of the Company’s Series A Convertible Preferred Stock, $0.0001 par value per share (“Series A Preferred Stock”). Pursuant to the A&R Ionic ATM Waiver, Ionic waived any prohibition, restriction or adverse adjustment that would otherwise apply to any action of the Company relating to an “at the market offering” (as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the “Securities Act”)), under a sales agreement between the Company and A.G.P./Alliance Global Partners (“A.G.P.”) under which the Company may offer and sell through A.G.P., as sales agent, the Company’s shares of Class B Common Stock (“Class B Common Stock”), $0.0001 par value per share (“Waived A.G.P. ATM”), under the Securities Purchase Agreement, dated as of May 24, 2024, between the Company and Ionic, as amended by the First Amendment to Securities Purchase Agreement, dated as of June 13, 2024, between the Company and Ionic (as amended, the “Ionic Purchase Agreement”), or the Series A Certificate of Designation of Series A Convertible Preferred Stock of the Company filed with the Secretary of State of the State of Nevada on May 24, 2024, as amended by the Certificate of Amendment to Designation filed with the Secretary of State of the State of Nevada on June 14, 2024, as amended by the Certificate of Amendment to Designation of Series A Convertible Preferred Stock filed with the Secretary of State of the State of Nevada on September 4, 2024 at 9:58 AM Pacific Time, as amended by the Certificate of Amendment to Designation of Series A Convertible Preferred Stock filed with the Secretary of State of the State of Nevada on September 4, 2024 at 11:38 AM Pacific Time (as amended, the “Series A Certificate of Designation”). Pursuant to the A&R Ionic ATM Waiver, regardless of the terms and conditions of the Ionic Purchase Agreement and the Series A Certificate of Designation, the Company may at any time enter into or consummate the transactions contemplated by any agreement relating to a Waived A.G.P. ATM, the filing of a prospectus supplement to a prospectus contained in an effective registration statement that was filed under the Securities Act relating to a Waived A.G.P. ATM, the announcement of a Waived A.G.P. ATM, the issuance, offer, sale, or grant of any shares of the Class B Common Stock relating to a Waived A.G.P. ATM, or the issuance, offer, sale, or grant of any securities in connection with either the provision of goods or services or settlement of any obligations that may otherwise arise with respect to a Waived A.G.P. ATM. In addition, pursuant to the A&R Ionic ATM Waiver, Ionic waived any adjustment to the applicable Conversion Price (as defined in the Series A Certificate of Designation), which partly determines the number of shares of Class B Common Stock issuable upon conversion of a share of Series A Preferred Stock, that would otherwise occur as a result of any Waived A.G.P. ATM under the terms of the Series A Certificate of Designation.

 

A copy of the A&R Ionic ATM Waiver is filed as Exhibit 10.1 to this Current Report on Form 8-K, and the description above is qualified in its entirety by reference to the full text of such exhibit.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.		Description
10.1		Amended and Restated Waiver and Consent, dated as of March 20, 2025, between Asset Entities Inc. and Ionic Ventures, LLC
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 20, 2025	ASSET ENTITIES INC.
	/s/ Arshia Sarkhani
	Name:	Arshia Sarkhani
	Title:	Chief Executive Officer and President

 

 

2

Exhibit 10.1

 

AMENDED AND RESTATED

WAIVER AND CONSENT

 

AMENDED AND RESTATED WAIVER AND CONSENT, dated as of March 20, 2025 (this “Waiver and Consent”). by and between Asset Entities Inc., a Nevada corporation (the “Company”) and Ionic Ventures, LLC, a California limited liability company (the “Investor”). Each of the Company and the Investor are sometimes referred to in this Agreement individually as a “Party” and, collectively, as the “Parties.”

 

RECITALS

 

A. The Company has conducted, and intends to continue to conduct, an “at the market offering” (as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”)), under a sales agreement (as amended from time to time, the “ATM Agreement”) between the Company and A.G.P./Alliance Global Partners (“A.G.P.”), under which the Company may offer and sell through A.G.P., as sales agent, the Company’s shares (“Shares”) of Class B Common Stock, $0.0001 par value per share (an “ATM”).

 

B. Certain provisions of that certain Certificate of Designation of Series A Convertible Preferred Stock of Asset Entities Inc. filed with the Secretary of State of the State of Nevada on May 24, 2024, as amended by that certain Certificate of Amendment to Designation of Asset Entities Inc. filed with the Secretary of State of the State of Nevada on June 14, 2024, as amended by that certain Certificate of Amendment to Designation of Series A Convertible Preferred Stock of Asset Entities Inc. filed with the Secretary of State of the State of Nevada on September 4, 2024, as amended by that certain Certificate of Amendment to Designation of Series A Convertible Preferred Stock of Asset Entities Inc. filed with the Secretary of State of the State of Nevada on September 4, 2024 (as amended, the “Certificate of Designation”), and that certain Securities Purchase Agreement, dated as of May 24, 2024, by and among the Company, and each of the investors listed on the Schedule of Buyers attached hereto, as amended by that certain First Amendment to Securities Purchase Agreement, dated as of June 13, 2024, by and between the Company and the Investor (as amended, the “Securities Purchase Agreement”), may prohibit, restrict, or adversely adjust the terms thereof as a result of any ATM conducted by the Company.

 

C. The Parties have determined that it is in their mutual interest to waive any prohibition, restriction, or adverse adjustments under the Certificate of Designation or the Securities Purchase Agreement that may be applicable to an ATM.

 

D. The Parties therefore wish to confirm that any prohibition, restriction or adverse adjustments under the Certificate of Designation or the Securities Purchase Agreement that may be applicable to an ATM shall hereby be waived in their entirety pursuant to this Waiver and Consent, and that the Investor consents to such waiver.

 

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the mutual promises herein contained, the Parties, intending to be legally bound, hereby agree as follows:

 

1. Definitions; Transaction Documents. This Waiver and Consent shall constitute a waiver pursuant to Section 22 of the Certificate of Designation and under subsection (e) of Section 9 of the Securities Purchase Agreement.

 

2. Waiver of Application of Certain Provisions With Respect to ATMs and Consent Thereto. The Investor hereby waives and consents to the waiver of any prohibition on, restriction on, or adverse adjustment that would occur as a result of any action of the Company in relation to an ATM, including entering into or consummating the transactions contemplated by the ATM Agreement or any other agreement relating to an ATM, the filing of a prospectus supplement to a prospectus contained in an effective registration statement that was filed under the Securities Act relating to an ATM, the announcement of an ATM, the issuance, offer, sale, or grant of any Shares relating to an ATM, or the issuance, offer, sale, or grant of any securities in connection with either the provision of goods or services or settlement of any obligations that may otherwise arise with respect to an ATM (the “Waived Matters”), under the Securities Purchase Agreement or the Certificate of Designation, including but not limited to (i) any prohibition against any of the Waived Matters that may otherwise apply under Section 13(i) of the Certificate of Designation; (ii) any application of any adjustment of the Conversion Price (as defined in the Certificate of Designation) under subsection (a), (c), or (e) of Section 8 of the Certificate of Designation with respect to any of the Waived Matters; (iii) any prohibition on any Subsequent Placement (as defined by the Securities Purchase Agreement) during the Restricted Period (as defined by the Securities Purchase Agreement) that would otherwise apply with respect to the Waived Matters under Section 4(k) of the Securities Purchase Agreement; or (iv) any restriction that may otherwise apply with respect to the Waived Matters during any active Alternate Conversion Measuring Period under Section 4(n) of the Securities Purchase Agreement. The application of any such prohibition against, restriction on, or adverse adjustment that would occur as a result of any of the Waived Matters are hereby waived in their entirety, and the Investor hereby consents to such waiver. The Investor waives any right to exercise, enforce, or attempt to exercise or enforce any such prohibition against, restriction on, or adverse adjustment that would occur as a result of any of the Waived Matters, and the Investor consents to the foregoing.

 

3. Conditions to Effectiveness of Waiver and Consent. This Waiver and Consent shall become effective upon receipt by the Company and the Investor of counterpart signatures to this Waiver and Consent duly executed and delivered by the Company and the Investor.

 

4. No Implied Waiver or Consent. Except as expressly set forth in this Waiver and Consent, this Waiver and Consent shall not, by implication or otherwise, limit, impair, constitute a waiver of or otherwise affect any rights or remedies of the Investor under the Certificate of Designation, the Securities Purchase Agreement, or the Articles of Incorporation (as amended from time to time) or Bylaws (as amended from time to time) of the Company, or alter, modify, amend or in any way affect any of the terms, obligations or covenants contained therein. Nothing in this Waiver and Consent shall be construed to imply any willingness on the part of the Investor to agree to or grant any similar or future amendment, consent or waiver of any of the terms and conditions of any of the Preferred Shares (as defined in the Securities Purchase Agreement).

 

 

5. Fees and Expenses. The Company agrees to pay promptly to the Investor or reimburse the Investor for all the actual and reasonable costs, fees and expenses of negotiation, preparation and execution of this Waiver and Consent, including the reasonable fees, expenses and disbursements of counsel to the Investor in connection therewith.

 

6. Counterparts. This Waiver and Consent may be executed by the Parties in several counterparts, each of which shall be an original and all of which shall constitute together but one and the same agreement. Delivery of an executed counterpart of a signature page of this Waiver and Consent by e-mail (e.g., “pdf” or “tiff”) or fax transmission shall be effective as delivery of a manually executed counterpart of this Waiver and Consent.

 

7. Governing Law. THIS WAIVER AND CONSENT SHALL BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEVADA APPLICABLE TO CONTRACTS MADE AND TO BE PREPARED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES.

 

8. Binding Agreement. This Waiver and Consent shall inure to the benefit of and be binding upon each of the Parties and each of their respective successors and assigns.

 

9. Headings. The headings in this Waiver and Consent are for reference only and do not affect the interpretation of this Waiver and Consent.

 

10. Complete Agreement. This Waiver and Consent constitutes the sole and entire agreement of the Parties with respect to the subject matter contained herein and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, with respect to such subject matter.

 

[Remainder of Page Intentionally Left Blank.]

 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Waiver and Consent to be duly executed and delivered as of the date first set forth above.

 

Asset Entities Inc.
By:	/s/ Arshia Sarkhani
Name:	Arshia Sarkhani
Title:	Chief Executive Officer
Ionic Ventures, LLC
By:	/s/ Brendan O’Neil
Name:	Brendan O’Neil
Title:	Authorized Signatory

 

 

4

v3.25.1

Cover	Mar. 20, 2025
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Mar. 20, 2025
Entity File Number	001-41612
Entity Registrant Name	ASSET ENTITIES INC.
Entity Central Index Key	0001920406
Entity Tax Identification Number	88-1293236
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	100 Crescent Ct
Entity Address, Address Line Two	7th Floor
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75201
City Area Code	214
Local Phone Number	459-3117
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Class B Common Stock, $0.0001 par value per share
Trading Symbol	ASST
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

---